Company Overview
American Healthcare Capital is pleased to introduce a Digital Health software developer providing a software and medical device solution for enterprise endoscopic video and image recording, archiving, and integration. The Company is a premier solution for medical media that includes capture, storage, collaboration tools, and integration with EHR platforms.
The Company leads with secure and user-friendly end-to-end solutions for image, video, and Surgical Reporting integration from patient scheduling to discharge, especially in support of endoscopy, laparoscopy, microscopy procedures, and robotics. The software enables medical specialists to document procedures, manage workflow, and facilitate reporting with the latest in video and image capture and integration technology. The result is better patient care and a more efficient medical environment. The Platform is flexible, versatile and scalable, giving enterprise healthcare a solid foundation for a unified digital imaging archive (UDIA) with metadata analytics capabilities.
The Software is an FDA Class 1 Medical Device. Flexibility enables healthcare organizations to give doctors immediate access to all of a patient’s imaging studies, including MRI, CT scans and X-rays, video from scopes and cameras, still images, and audio recordings. Full System Integration improves workflow, referrals, and patient satisfaction by integrating videos, images, and audio files into existing medical media software platforms.
Financial Overview
The U.S. digital health market size was valued at USD 77.0 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 17.10% from 2023 to 2030. The supportive environment for digital healthcare services and improved internet connectivity to deliver remote healthcare services using digital routes are anticipated to drive market growth over the forecast years.
The Company has been successful at selling its software and products directly to high-profile medical institutions, with multiple established relationships prospering beyond 10-12 years. Ongoing growth areas for the company include federal sales with a $45 million 5-year Department of Defense Contract and through co-marketing partners. The company is at an inflection point with high-growth revenue contracts being implemented during the forecast period. The past 3 years had consistent revenues of approximately $2 million per year. The company is monetizing its sales pipeline and projecting 2024 revenues of $4.2 million with an adjusted EBITDA of $800,000. The high growth 3-year forecast is expected to deliver 2026 revenues of $9.7 million and adjusted EBITDA of $3.2 million or 33% adjusted EBITDA margin.
Asking Price
The Company is looking for a strategic or financial partner to add value through its connections, economic strength, and resources to grow the Company to the next level. Therefore, the founders will consider a majority equity investment or buyout in support of the future growth potential for this digital health technology platform.
The Price is to Be Determined, and the sellers will consider an Earnout Going Forward.
